These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The natural history of the Guillain-Barré syndrome in 18 children and 50 adults. Kleyweg RP; van der Meché FG; Loonen MC; de Jonge J; Knip B J Neurol Neurosurg Psychiatry; 1989 Jul; 52(7):853-6. PubMed ID: 2769279 [TBL] [Abstract][Full Text] [Related]
7. Plasma exchange and selective adsorption in Guillain-Barré syndrome--a comparison of therapies by clinical course and side effects. Rosenow F; Haupt WF; Grieb P; Jiménez-Klingberg C; Borberg H Transfus Sci; 1993 Jan; 14(1):13-5. PubMed ID: 10148310 [TBL] [Abstract][Full Text] [Related]
8. [Acute Guillain-Barré syndrome: what is new?]. Sebire G; Tardieu M Pediatrie; 1993; 48(9):607-10. PubMed ID: 8015876 [No Abstract] [Full Text] [Related]
9. The Guillain-Barré syndrome: plasma exchange or immunoglobulins intravenously? van der Meché FG Ann Med Interne (Paris); 1994; 145(5):293-5. PubMed ID: 7985934 [No Abstract] [Full Text] [Related]
10. Plasma exchange and i.v.-immunoglobulins: new approaches to the treatment of Guillain-Barre' syndrome. Fasanaro AM; Pizza V; Stella L Acta Neurol (Napoli); 1992; 14(4-6):369-80. PubMed ID: 1293980 [TBL] [Abstract][Full Text] [Related]
11. [Functional recovery in Guillain-Barre syndrome: benefits of plasma exchange]. Cassuto-Viguier E; Sanderson F; Kullman B; Quaranta JF; Montagne N; Gueyraud A; Therre C; Duplay H Ann Med Interne (Paris); 1988; 139 Suppl 1():43-5. PubMed ID: 3247991 [TBL] [Abstract][Full Text] [Related]
12. Outcome in severe pediatric Guillain-Barré syndrome after immunotherapy or supportive care. Graf WD; Katz JS; Eder DN; Smith AJ; Chun MR Neurology; 1999 Apr; 52(7):1494-7. PubMed ID: 10227643 [TBL] [Abstract][Full Text] [Related]
13. Is there a scientific rationale for therapeutic plasma exchange or intravenous immune globulin in the treatment of acute Guillain-Barré syndrome? Weinstein R J Clin Apher; 1995; 10(3):150-7. PubMed ID: 8582898 [No Abstract] [Full Text] [Related]
14. A randomized trial comparing intravenous immunoglobulin and plasma exchange in Guillain-Barré syndrome. Kleyweg RP; van der Meché FG; Schmitz PI Transfus Sci; 1994 Dec; 15(4):389-92. PubMed ID: 10172508 [No Abstract] [Full Text] [Related]
15. Plasma exchange in the treatment of Guillain-Barré syndrome: experience in a sub-regional referral centre. Anderson NA; Kyriakides T; Ferguson IT; Wallington TB Postgrad Med J; 1991 Feb; 67(784):154-6. PubMed ID: 2041845 [TBL] [Abstract][Full Text] [Related]
16. Plasma exchange in the Guillain-Barré syndrome. Lancet; 1984 Dec; 2(8415):1312-3. PubMed ID: 6150327 [No Abstract] [Full Text] [Related]
17. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. Dutch Guillain-Barré Study Group. van der Meché FG; Schmitz PI N Engl J Med; 1992 Apr; 326(17):1123-9. PubMed ID: 1552913 [TBL] [Abstract][Full Text] [Related]
18. Risk factors for treatment related clinical fluctuations in Guillain-Barré syndrome. Dutch Guillain-Barré study group. Visser LH; van der Meché FG; Meulstee J; van Doorn PA J Neurol Neurosurg Psychiatry; 1998 Feb; 64(2):242-4. PubMed ID: 9489539 [TBL] [Abstract][Full Text] [Related]
19. The Italian Guillain-Barré Study Group. The prognosis and main prognostic indicators of Guillain-Barré syndrome: a multicentre prospective study of 297 patients. Hughes RA; Hadden RD; Rees JH; Swan AV Brain; 1998 Apr; 121 ( Pt 4)():767-9. PubMed ID: 9577400 [No Abstract] [Full Text] [Related]
20. Plasma exchange for Guillain-Barré syndrome. Hughes RA Br Med J (Clin Res Ed); 1985 Sep; 291(6496):615-6. PubMed ID: 3928050 [No Abstract] [Full Text] [Related] [Next] [New Search]